Total Valuation
MindMaze Therapeutics Holding SA has a market cap or net worth of CHF29.70M. The enterprise value is CHF16.26.
Market CapCHF29.70M
Enterprise ValueCHF16.26
Share Statistics
MindMaze Therapeutics Holding SA has 181,497,670 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding181,497,670
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
MindMaze Therapeutics Holding SA’s return on equity (ROE) is -0.47 and return on invested capital (ROIC) is -34.28%.
Return on Equity (ROE)-0.47
Return on Assets (ROA)-0.32
Return on Invested Capital (ROIC)-34.28%
Return on Capital Employed (ROCE)-0.39
Revenue Per Employee841.70K
Profits Per Employee-1.71M
Employee Count10
Asset Turnover0.16
Inventory Turnover2.47
Valuation Ratios
The current PE Ratio of MindMaze Therapeutics Holding SA is ―. MindMaze Therapeutics Holding SA’s PEG ratio is 0.04.
PE Ratio―
PS Ratio6.27
PB Ratio1.44
Price to Fair Value1.44
Price to FCF-17.10
Price to Operating Cash Flow-11.00
PEG Ratio0.04
Income Statement
In the last 12 months, MindMaze Therapeutics Holding SA had revenue of 8.42M and earned -17.12M in profits. Earnings per share was -1.36.
Revenue8.42M
Gross Profit5.84M
Operating Income-18.89M
Pretax Income-19.36M
Net Income-17.12M
EBITDA-16.73M
Earnings Per Share (EPS)-1.36
Cash Flow
In the last 12 months, operating cash flow was -3.40M and capital expenditures -26.00K, giving a free cash flow of -3.43M billion.
Operating Cash Flow-3.40M
Free Cash Flow-3.43M
Free Cash Flow per Share-0.02
Dividends & Yields
MindMaze Therapeutics Holding SA pays an annual dividend of CHF0.285, resulting in a dividend yield of 1.16%
Dividend Per ShareCHF0.285
Dividend Yield1.16%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.25
52-Week Price Change-94.21%
50-Day Moving Average0.19
200-Day Moving Average0.81
Relative Strength Index (RSI)39.37
Average Volume (3m)214.31K
Important Dates
MindMaze Therapeutics Holding SA upcoming earnings date is Aug 27, 2026, Before Open (Confirmed).
Last Earnings DateApr 9, 2026
Next Earnings DateAug 27, 2026
Ex-Dividend Date―
Financial Position
MindMaze Therapeutics Holding SA as a current ratio of 3.95, with Debt / Equity ratio of 5.82%
Current Ratio3.95
Quick Ratio3.74
Debt to Market Cap0.00
Net Debt to EBITDA0.77
Interest Coverage Ratio-273.70
Taxes
In the past 12 months, MindMaze Therapeutics Holding SA has paid -2.24M in taxes.
Income Tax-2.24M
Effective Tax Rate0.12
Enterprise Valuation
MindMaze Therapeutics Holding SA EV to EBITDA ratio is -2.38, with an EV/FCF ratio of -12.91.
EV to Sales4.74
EV to EBITDA-2.38
EV to Free Cash Flow-12.91
EV to Operating Cash Flow-13.67
Balance Sheet
MindMaze Therapeutics Holding SA has CHF12.50M in cash and marketable securities with CHF1.90M in debt, giving a net cash position of CHF10.60M billion.
Cash & Marketable SecuritiesCHF12.50M
Total DebtCHF1.90M
Net CashCHF10.60M
Net Cash Per ShareCHF0.06
Tangible Book Value Per ShareCHF0.45
Margins
Gross margin is -29.03%, with operating margin of -224.37%, and net profit margin of -203.39%.
Gross Margin-29.03%
Operating Margin-224.37%
Pretax Margin-229.96%
Net Profit Margin-203.39%
EBITDA Margin-198.72%
EBIT Margin-229.14%
Analyst Forecast
The average price target for MindMaze Therapeutics Holding SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―